Analysis – Page 54 – Goldea Capital

Synaptics Announces Fiscal Fourth Quarter 2026 Investor Conference Participation

Written by Customer Service on May 12, 2026. Posted in Public Companies.

SAN JOSE, Calif., May 12, 2026 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced its participation in the following investor conferences in the fiscal fourth quarter of 2026:Rahul Patel, President and Chief Executive Officer, will present at the J.P. Morgan 2026 Global Technology, Media and Communications Conference on Monday, May 18, 2026, at 6:05 AM PT. To view the webcast or access a replay, please visit J.P. Morgan 2026 Global Technology, Media and Communications Conference. Ken Rizvi, Chief Financial Officer, will participate in TD Cowen 54th Annual Technology, Media & Telecom Conference on Wednesday, May 27, 2026. Ken Rizvi, Chief Financial Officer, will present at the Mizuho Technology Conference 2026 on Tuesday, June 9, 2026 at 6:45 AM PT. To view the webcast or access a replay, please visit...

Salem Media to Be Acquired by WaterStone in Major Growth Deal

Written by Customer Service on May 12, 2026. Posted in Mergers And Acquisitions.

CAMARILLO, Calif., May 12, 2026 (GLOBE NEWSWIRE) — Salem Media, Inc. (OTCQX: SALM) today announced it has entered into a definitive agreement to be acquired by The Christian Community Foundation, Inc., d/b/a WaterStone in a transaction that will take the company private and strengthen Salem’s long-term mission across radio, digital media, streaming, podcasting, television, and publishing. Under the terms of the agreement, WaterStone will acquire all outstanding shares of Salem Media common stock for $1.00 per share, representing approximately a 250% premium over Salem’s recent trading price. Edward Atsinger III, Salem co-founder and board member, said finding the right long-term steward for the company was a priority. “For the last ten years the Atsinger and Epperson families have been looking for a successor that would continue...

Gencor Industries, Inc. Withdraws and Retracts Preliminary Second Quarter Fiscal 2026 Earnings Release

Written by Customer Service on May 12, 2026. Posted in Earnings Releases And Operating Results.

ORLANDO, Fla., May 12, 2026 (GLOBE NEWSWIRE) — Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) hereby withdraws and retracts its press release dated May 8, 2026, titled “Gencor Industries, Inc. Releases Second Quarter Fiscal 2026 Results” (the “Prior Release”). The Prior Release was issued before the Company had completed its review of the Company’s financial statements for the quarter ended March 31, 2026 and should be disregarded in its entirety. Investors and other recipients should not rely on any information contained in the Prior Release, including the preliminary results of operations for the quarter ended March 31, 2026 reported therein. The Company cautions that no conclusions should be drawn from the Prior Release regarding the Company’s actual financial condition, results of operations, or business...

Finning reports Q1 2026 results

Written by Customer Service on May 12, 2026. Posted in Earnings Releases And Operating Results.

VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) — Finning International Inc. (TSX: FTT) (“Finning”, the “Company”, “we”, “our” or “us”) reported first quarter 2026 results today. All monetary amounts are in Canadian dollars unless otherwise stated and all financial information in this earnings release represents the results from continuing operations, unless otherwise noted. (1) HIGHLIGHTSAll comparisons are to Q1 2025 results unless indicated otherwise.Revenue of $2.5 billion was up 2%, led by product support growth in Canada. Product support revenue increased 6% with growth across all market sectors. Q1 2026 was the 8th quarter in a row of year-over-year product support growth. SG&A (2) margin (3) was 16.0% and included $15 million of LTIP (2) expense due to strong first quarter share price performance. EBIT...

Sanuwave Announces Revenues and Financial Results for Q1 FY2026

Written by Customer Service on May 12, 2026. Posted in Earnings Releases And Operating Results.

Q1 2026 revenues were $9.6 million, up 3.1% from $9.3 million in Q1 2025. This represents the highest Q1 quarterly revenues in Company history. Q1 2026 gross margin was 77.3%, versus 79.0% in Q1 2025. GAAP Operating Loss was $1.1 million for Q1 2026, a swing of $1.7 million from operating income of $0.6 million in Q1 2025. Company provides guidance for revenue growth of 10-15% for Q2 2026 as compared to Q2 2025EDEN PRAIRIE, Minn., May 12, 2026 (GLOBE NEWSWIRE) — Sanuwave Health, Inc. (the “Company” or “Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to provide its financial results for the three months ended March 31, 2026. Q1 2026 ended March 31, 2026Revenue for the three months ended March 31, 2026, totaled $9.6 million, an increase of 3.1%,...

Total Energy Services Inc. Announces Q1 2026 Results

Written by Customer Service on May 12, 2026. Posted in Earnings Releases And Operating Results.

CALGARY, Alberta, May 12, 2026 (GLOBE NEWSWIRE) — Total Energy Services Inc. (“Total Energy” or the “Company”) (TSX:TOT) announces its consolidated financial results for the three months ended March 31, 2026. Financial Highlights ($000’s except per share data, unaudited) Three months endedMarch 31 2026 2025 ChangeRevenue $ 314,896 $ 251,909 25 %Operating income 27,129 26,063 4 %EBITDA(1) 55,158 50,488 9 %Cashflow 54,290 44,934 21 %Net income 24,222 18,952 28 %Attributable to shareholders 24,137 18,966 27 % Per Share Data (Diluted) EBITDA(1) $ 1.49 $ 1.31 14 %Cashflow $ 1.46 $ 1.16 26 % Attributable to shareholders: Net income $ 0.65 $ 0.49 33 % Common...

Eupraxia Pharmaceuticals Reports First Quarter 2026 Financial Results

Written by Customer Service on May 12, 2026. Posted in Earnings Releases And Operating Results.

Robust response in highest dose cohort after 36 weeks following a single treatment of EP-104GI Completion of a $63.2 million public offering to enable clinical trials of EP-104GI in additional indications Well-capitalized into H2 2028, beyond key catalysts with over $140 million cash VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the first quarter of 2026. “The clinical data reported this quarter further reinforces the potential for EP-104GI to become an important new...

ArrowMark Financial Corp. Announces Monthly Cash Distribution of $0.15 per Share for May 2026

Written by Customer Service on May 12, 2026. Posted in Dividend Reports And Estimates.

DENVER, May 12, 2026 (GLOBE NEWSWIRE) — ArrowMark Financial Corp. (Nasdaq: BANX) (“ArrowMark Financial” or the “Company”), an SEC registered closed-end management investment company, today announced that its Board of Directors has declared a monthly cash distribution of $0.15 per share for May 2026. The total distribution of $0.15 per share will be payable on May 29, 2026, to shareholders of record on May 22, 2026. “We are very pleased to announce the regular monthly distribution of $0.15. We believe these distributions reflect the Fund’s ability to consistently over-earn its declared monthly distribution rate. ArrowMark Financial is committed to providing consistent risk-adjusted returns while maintaining focus on capital preservation and income generation for our shareholders,” said Chairman & CEO...

Allied Announces Voting Results from the 2026 Annual Meeting of Unitholders

Written by Customer Service on May 12, 2026. Posted in Public Companies.

TORONTO, May 12, 2026 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) announced today the results of matters voted on at its annual meeting of the holders (the “Unitholders”) of units and special voting units of Allied (collectively, “Units”) held on May 12, 2026 (the “Meeting”). All of the nominees for election as trustees listed in Allied’s management information circular (the “Circular”) dated March 31, 2026, were elected as trustees of Allied for the ensuing year or until their successors are elected or appointed. Management received proxies in respect of the election of trustees of Allied as follows: VOTES FOR VOTES WITHHELD # % # %Matthew Andrade 91,340,837 82.34% 19,591,881 17.66%Mario Barrafato 109,614,857 98.82% 1,312,261 1.18%Kay Brekken 91,436,502 82.43% 19,496,216 17.57%Hazel...

COSCIENS Biopharma Inc. Reports Q1 2026 Results

Written by Customer Service on May 12, 2026. Posted in Public Companies.

TORONTO, ONTARIO, May 12, 2026 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (TSX: CSCI) (OTCQB: CSCIF) (“COSCIENS” or the “Company”) today reported its financial and operating results for the first quarter ended March 31, 2026. All amounts in this press release are in U.S. dollars. Q1 2026 Financial Highlights$5.0 million in cash and cash equivalents at March 31, 2026. Consolidated net income of $10.8 million or $3.42 net income per common share, as compared with a consolidated net loss of $3.7 million, or $1.16 loss per common share for Q1 2025. The $14.4 million increase in net income is primarily attributable to the $10.9 million of Income from discontinued operations recognized upon the deconsolidation of the Company’s German subsidiaries from the consolidated financial results (as further discussed below). Consolidated net...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals